Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
© Bisgin et al; licensee BioMed Central Ltd. 2012
Received: 10 May 2011
Accepted: 7 February 2012
Published: 7 February 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|10 May 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|27 Jun 2011||Reviewed||Reviewer Report - Girolamo Ranieri|
|30 Jun 2011||Reviewed||Reviewer Report - Bruce Giantonio|
|21 Sep 2011||Author responded||Author comments - ATIL BISGIN|
|Resubmission - Version 3|
|21 Sep 2011||Submitted||Manuscript version 3|
|24 Sep 2011||Reviewed||Reviewer Report - Girolamo Ranieri|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|7 Feb 2012||Editorially accepted|
|7 Feb 2012||Article published||10.1186/1471-2407-12-58|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.